Greenstone LLC Recalls Methylprednisolone Dosepak Tablets Due to Dosing Labeling Error
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Greenstone LLC has voluntarily recalled one lot of Methylprednisolone 4 mg Dosepak tablets because incorrect blister foil orientation provides inaccurate dosing instructions to patients.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, pharmaceuticals.
What Happened
Greenstone LLC has initiated a voluntary recall of one lot of Methylprednisolone tablets, USP Dosepak, 4 mg. The recall was prompted by a labeling error involving the incorrect orientation of the blister foil applied to the blister cavities. This manufacturing defect results in incorrect dosing information when a patient follows the directions printed on the foil.
Which Products Are Affected
The recall affects 3,456 cartons of the following product distributed nationwide within the United States:
- Product Name: Methylprednisolone tablets, USP Dosepak, 4 mg
- Configuration: 1 Blister Card per Carton containing 21 Tablets
- NDC (National Drug Code): 59762-4440-2
- Lot Number: LG7675
- Expiration Date: Nov 2026
- UPC: 0359762444035
- Manufacturer: Mylan Pharmaceuticals Inc.
- Distributor: Greenstone LLC, Peapack, NJ
What You Should Do
Consumers and healthcare providers should immediately check their supply for Lot # LG7675. If you have the affected product, you should contact your physician or pharmacist regarding the correct dosing schedule or to obtain a replacement. Patients should not follow the dosing instructions printed on the blister foil of the affected lot. For further information, consumers may contact the recalling firm, Greenstone LLC, based in Peapack, New Jersey.
Why This Matters
This recall is significant because the incorrect orientation of the foil leads to inaccurate dosing instructions. Following incorrect directions for a prescription corticosteroid could result in a patient receiving the wrong dose, potentially leading to ineffective treatment or adverse health consequences.
Source
Information provided by the U.S. Food and Drug Administration (FDA). Recall Number: D-0299-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.